A stabilised analogue of growth-hormone-releasing hormone.
PRODUCT PROFILE
Tesamorelin
£52.99
Tesamorelin is a laboratory-made version of a natural hormone signal that tells the pituitary gland to release growth hormone. Researchers study its effects on growth-hormone signalling and body-fat distribution. An authorised prescription version exists for one specific condition, which does not make this research listing a general weight-loss product.
Why it is distinct
It is the GHRH analogue in this catalogue with an authorised indication and outcome trials for a defined patient group.
- Evidence stageEstablished clinical evidence
- AvailabilityAvailable · 50 in stock
- Batch recordOpen COA
- DispatchConfirmed at checkout
50 in stock
SUGGESTED ADD-ONS
Useful additions, clearly shown.
Suggestions are organised by vial format and catalogue context. They are not combined-use guidance or personal-use advice.
-
Specification review
Bacteriostatic Water
Price range: £4.49 through £8.9910 mL | 3 mLBatch file pendingA laboratory supply with two volume variants, not a peptide or biologically active comparison material.
Available · select size for stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Early human evidence
CJC-1295 DAC
Price range: £32.99 through £39.995 mgBatch COA availableIts albumin-binding extension creates sustained exposure, unlike CJC-1295 No DAC or sermorelin.
Available · select size for stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Early human evidence
Ipamorelin
Price range: £34.99 through £54.995 mgBatch COA availableA ghrelin-receptor secretagogue—not a GHRH analogue—and generally discussed as more selective than older GHRPs.
Available · select size for stockAdd to basket This product has multiple variants. The options may be chosen on the product page
PRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
Tesamorelin is a laboratory-made version of a natural hormone signal that tells the pituitary gland to release growth hormone. Researchers study its effects on growth-hormone signalling and body-fat distribution. An authorised prescription version exists for one specific condition, which does not make this research listing a general weight-loss product.
Research focus+
Clinical research includes growth-hormone signalling and reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. It is not established as a general wellness or weight-loss treatment.
How the mechanism differs+
It activates the GHRH receptor upstream of the pituitary, encouraging the body to release its own growth hormone.
Evidence and limitations+
An authorised prescription medicine exists for a specific HIV-lipodystrophy indication. Evidence and approval do not extend automatically to other purposes or research products.
Testing and batch documentation+
Verified batch documents are available for review.
RESEARCH PROFILE
Understand the distinction.
Clinical research includes growth-hormone signalling and reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. It is not established as a general wellness or weight-loss treatment.
It activates the GHRH receptor upstream of the pituitary, encouraging the body to release its own growth hormone.
It is the GHRH analogue in this catalogue with an authorised indication and outcome trials for a defined patient group.
An authorised prescription medicine exists for a specific HIV-lipodystrophy indication. Evidence and approval do not extend automatically to other purposes or research products.
Educational research context only. This information is not dosage, administration or personal-use guidance.
CONTINUE EXPLORING
Related research perspectives.
Selected for useful comparison across neighbouring or contrasting research areas—not as combined-use guidance.
-
Preclinical
BPC-157
£32.99Batch COA availableBPC-157 is mainly discussed around stomach and local tissue-repair models. TB-500 is instead studied for actin, cell movement…
Available · 30 in stockAdd to basket -
Preclinical
TB-500
£32.99Batch COA availableTB-500 is discussed as a fragment-like repair material, while thymosin beta-4 is the full natural protein and BPC-157…
Available · 30 in stockAdd to basket